Treats schizophrenia. ANDA 72062, held by Watson Labs. Loxapine Succinate.
As of Nov 16, 2026, ANDA 72062 (Loxapine Succinate), held by Watson Labs, was first approved by FDA on Jun 15, 1988, with 17 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Loxapine capsules are indicated for the treatment of schizophrenia. The efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 15, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Loxapine SuccinateEQ 50MG BASE · capsule;oral | Loxapine Succinate | Rx |
| Jul 30, 2025 | Supplement 44Labeling · Standard review | Approved | None posted |
| Jan 22, 2025 | Supplement 39Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 34Labeling · Standard review | Approved | None posted |
| Dec 3, 2010 | Supplement 28Labeling | Approved | None posted |
| Jun 4, 2009 | Supplement 27Labeling | Approved | None posted |
| Sep 8, 2008 | Supplement 25Labeling | Approved | None posted |
| Sep 3, 2008 | Supplement 22Labeling | Approved | None posted |
| Dec 2, 2002 | Supplement 11Labeling | Approved | None posted |
| Jun 17, 2002 | Supplement 12Manufacturing | Approved | None posted |
| Mar 29, 2000 | Supplement 9Labeling | Approved | None posted |
| Mar 29, 2000 | Supplement 8Manufacturing | Approved | None posted |
| Jan 14, 2000 | Supplement 10Manufacturing | Approved | None posted |
| Nov 25, 1997 | Supplement 7Manufacturing | Approved | None posted |
| Feb 13, 1997 | Supplement 6Labeling | Approved | None posted |
| Jul 31, 1992 | Supplement 5Labeling | Approved | None posted |
| Feb 1, 1991 | Supplement 4Labeling | Approved | None posted |
| Apr 11, 1989 | Supplement 3Labeling | Approved | None posted |
| Jun 15, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters